NCT02371187 - Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training? | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Physical Activity

Interventions

DRUG

Dapagliflozin

Dapagliflozin tablets, 5 mg, one per day for the first 14 days, increase to two per day for 70 days.

DRUG

Placebo

Matching placebo for Dapagliflozin 5 mg, one per day for the first 14 days, increase to two per day for 70 days.

Trial Locations (1)

Colorado State University, Dept. of Health and Exercise Science, Fort Collins